GLYQUIN XM SUMMARY
Each gram of Glyquin·XM™ contains 40 mg Hydroquinone USP, 80 mg Octocrylene USP, 40 mg Oxybenzone USP and 30 mg Avobenzone USP in a vanishing cream base.
Glyquin·XM™ is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.
Published Studies Related to Glyquin XM (Hydroquinone / Glycolic Acid)
Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. [2010.09]
Hydroquinone has been the standard prescription agent for skin lightening; however, its use recently has become controversial. Hydroquinone is banned in Europe and parts of Asia because of potential long-term consequences, including carcinogenesis when orally consumed... Thus this novel skin lightening preparation is an alternative to hydroquinone 4% for participants with mild to moderate facial dyschromia.
Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. [2008.08]
BACKGROUND: Chemical peels have become a popular modality in the treatment of melasma. The most disturbing side effect of this procedure is postinflammatory hyperpigmentation. This may be minimized with the help of priming agents. Because there is a paucity of such studies, this study was taken up to evaluate the beneficial effects of hydroquinone versus tretinoin as priming agents in treatment of melasma with glycolic acid peels... CONCLUSIONS: Results are better with hydroquinone as priming agent compared to tretinoin in enhancing the results with glycolic acid peels in melasma and in decreasing postpeel postinflammatory hyperpigmentation.
Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. [2003.12]
BACKGROUND: Melasma, also known as mask of pregnancy, is a common, acquired hypermelanosis seen in women with Fitzpatrick skin types II-V, and is often recalcitrant to treatment with depigmentation agents. Glycolic acid has been added to hydroquinone formulations in the past to enhance their depigmentation effects, but may cause irritation, leading to postinflammatory hyperpigmentation. AIM: To assess the safety and efficacy of a cream containing 4% hydroquinone, 10% buffered glycolic acid, vitamins C and E, and sunscreen (Glyquin, ICN Pharmaceuticals, Costa Mesa, USA) vs. a cream containing sunscreen alone in the depigmentation of epidermal melasma of the face... CONCLUSIONS: A cream containing 4% hydroquinone, 10% buffered glycolic acid, vitamins C and E, and sunscreen is safe and effective in the treatment of melasma.
Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest. [2000.04]
BACKGROUND: Salicylic acid, hydroquinone, and glycolic acid have been proved effective in the treatment of photodamaged facial skin. Few reports are available on the treatment of photodamage on the neck and upper chest. OBJECTIVE: This study's purpose was to evaluate the efficacy of a cream containing 4% hydroquinone and 2% glycolic acid (LUSTRA) used alone or with salicylic acid peels in reversing actinic damage on the neck and upper chest... CONCLUSION: Hydroquinone 4% cream with 2% glycolic acid is safe and effective in improving photodamage on the neck and upper chest when used alone or in combination with salicylic acid peels.
Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. [1999.04]
BACKGROUND: Melasma is difficult to clear. Many agents have been used, such as hydroquinone, and glycolic acid and glycolic acid peels, kojic acid, a tyrosinase inhibitor in the fungus Aspergilline oryzae. OBJECTIVE: To see if the addition of 2% kojic acid in a gel containing 10% glycolic acid and 2% hydroquinone will improve melasma further... CONCLUSION: The addition of kojic acid to a gel containing 10% glycolic acid and 2% hydroquinone further improves melasma.
Clinical Trials Related to Glyquin XM (Hydroquinone / Glycolic Acid)
Clinical Trial of Hydroquinone Versus Miconazol in Melasma [Recruiting]
Melasma is an acquired discoloration of the skin characterized by brown colour changes
commonly on the face. The duration of this double-blind clinical trial will be 12 weeks. The
control group will receive treatment with topical Hydroquinone (4%), and the other group
topical miconazole. Miconazol has antimelanotic properties and can be used as treatment for
melasma patients. The estimated number of subjects to be recruited and randomized for the
study is at least 30. The purpose of this study is determine if there is a difference in
the effectiveness of these two agents. Melasma Area and Severity Index (MASI) score will be
assessed at the beginning of the study and at weeks 4, 8, and 12. Photographs, colorimetry
and histological assessment will be also evaluated. Occurrence of adverse effects will also
Azelaic Acid Versus Hydroquinone in Melasma [Recruiting]
Efficacy and Safety of a 4% Hydroquinone Cream (Melanoderm 4%) for the Treatment of Melasma: a Randomized Controlled Split-face Study [Completed]
To assess the ability of a new 4% Hydroquinone formulation (Melanoderm 4% Crema) to reduce
melasma on the face, using a split-face randomization design, evaluating the MASI Score from
baseline to week 4 and week 8, in both half-faces receiving active treatment vs. placebo.
To assess the tolerance of a new 4% Hydroquinone formulation (Melanoderm 4% Crema) on the
To assess patients' satisfaction regarding Melanoderm 4% Crema after 8 weeks.
Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Chronic Low Back Pain [Completed]
To study the safety and efficacy of ARTRA (glucosamine chondroitin sulfate) in the treatment
of non-specific low-back pain of lumbosacral localization in ambulatory care.
Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly [Completed]
The purpose of this study is to evaluate whether low dose complex B-vitamins (folic
acid,vitamin B6 and vitamin B12) can lower the risk of developing hyperhomocysteinemia in an
apparently healthy population with low folate/B12 and high Hcy status.
PATIENT REVIEWS / RATINGS / COMMENTS
Based on a total of 1 ratings/reviews, Glyquin XM has an overall score of 3. The effectiveness score is 4 and the side effect score is 8. The scores are on ten point scale: 10 - best, 1 - worst.
Glyquin XM review by 38 year old female patient
|Overall rating:|| || |
|Effectiveness:|| || Marginally Effective|
|Side effects:|| || Mild Side Effects|
|Condition / reason:|| || melasma|
|Dosage & duration:|| || 1 small spoon (dosage frequency: every night) for the period of 3 months|
|Other conditions:|| || dark spots due to sun damage|
|Other drugs taken:|| || none|
|Benefits:|| || My skin has melasma so the treatment was supposed to clear up the brown spots mostly over my cheeks and nose. I didn't have a good experience since those signs are still there.|
|Side effects:|| || My eyes used to be kind of itchy and the skin, at the beginning of the treatment, used to be itchy and reddish too.|
|Comments:|| || In association with a glycolic peel (60%) once each 15 days I had Glyquin XM every night for, at least, 3 months. I used Photoderm MAX tint cream FSP 100 during the day.|
Page last updated: 2011-12-09